Aesther Healthcare Acquisition, a blank check company led by TRxADE Health executives targeting the pharma and medical device sectors, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.
The company is led by CEO and Chairman Suren Ajjarapu, co-founder and CEO of TRxADE Health (MEDS), an online marketplace for pharmaceutical companies that completed its Nasdaq IPO in February 2020. The company plans to target the pharmaceutical and medical device sectors.
Aesther Healthcare Acquisition plans to list on the Nasdaq under the symbol AEHAU. EF Hutton acted as sole bookrunner on the deal.
